CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2024; 8: (7) ; 75-77 ; DOI: 10.12208/j.ijcr.20240260.

Value of labetalol assisted magnesium sulfate in the treatment of patients with pregnancy-induced hypertension
拉贝洛尔辅助硫酸镁治疗妊高症患者的价值

作者: 普月 *

开远市人民医院 云南开远

*通讯作者: 普月,单位:开远市人民医院 云南开远;

发布时间: 2024-07-26 总浏览量: 240

摘要

目的 分析妊高症患者实施拉贝洛尔辅助硫酸镁治疗的价值。方法 采用2022年3月-2023年3月我院收治的69例妊高症患者,随机分为对照组35例,观察组34例,分别实行常规硫酸镁治疗、拉贝洛尔辅助硫酸镁治疗,对两组血压指标(收缩压、舒张压)、不良母婴结局(产后感染、产后出血、胎盘早剥、新生儿窒息)及并发症(子宫收缩、宫颈裂伤、子痫)发生情况比较。结果 与对照组相较,观察组收缩压、舒张压更低,不良母婴结局发生率、并发症发生率更低,差异均有统计学意义(P<0.05)。结论 妊高症患者实施拉贝洛尔辅助硫酸镁治疗应用价值高,有效改善患者血压指标,降低不良母婴结局发生率,减少并发症,治疗安全性较高,具有推广价值。

关键词: 拉贝洛尔;硫酸镁;治疗;妊高症

Abstract

Objective To analyze the value of implementing rabelol assisted magnesium sulfate treatment in patients with preeclampsia.
Methods A total of 69 patients with preeclampsia admitted to our hospital from March 2022 to March 2023 were randomly divided into a control group of 35 cases and an observation group of 34 cases. The two groups were treated with conventional magnesium sulfate therapy and labelol assisted magnesium sulfate therapy, respectively. The blood pressure indicators (systolic and diastolic blood pressure), adverse maternal and infant outcomes (postpartum infection, postpartum hemorrhage, placental abruption, neonatal asphyxia), and incidence of complications (uterine contractions, cervical lacerations, and eclampsia) were compared between the two groups.
Results Compared with the control group, the observation group had lower systolic and diastolic blood pressure, lower incidence of adverse maternal and infant outcomes, and lower incidence of complications, with statistical significance (P<0.05).
Conclusion   The application value of Labelol assisted magnesium sulfate treatment in patients with preeclampsia is high, which effectively improves blood pressure indicators, reduces the incidence of adverse maternal and infant outcomes, reduces complications, and has high treatment safety. It has promotional value.

Key words: Labelol; Magnesium sulphate; Treatment; Pih

参考文献 References

[1] 徐秀英. 早孕期血压高值对妊娠期高血压疾病的影响及相关危险因素分析 [J]. 黑龙江医药, 2024, 37 (03): 547-550. 

[2] 刘伟. 分析硫酸镁分别与拉贝洛尔及硝苯地平联合治疗妊高症子痫前期的价值 [J]. 系统医学, 2024, 9 (06): 150-153.

[3] 孙喆. 拉贝洛尔联合硫酸镁治疗妊高症临床疗效及对血压水平的影响研究 [J]. 实用妇科内分泌电子杂志, 2023, 10 (04): 74-76.

[4] 杨宁,李玉明.《国际高血压学会2020国际高血压实践指南》解读:妊娠期高血压疾病[J].中华高血压杂志,2020, 28(09):812-814.

[5] 王亚平,董雪妮. 高龄妊高症孕妇发生心血管并发症的影响因素分析 [J]. 临床医学研究与实践, 2022, 7 (34): 37-40. 

[6] 俞晶晶,刘玉琴,朱柳红. 高龄经产妇妊娠的临床特点 妊娠结局及相关影响因素分析 [J]. 中国妇幼保健, 2024, 39 (06): 1084-1087. 28.

[7] 万淼,闵魁. 拉贝洛尔与硫酸镁联合治疗重度妊娠期高血压疾病的疗效及对血压、血液流变学指标的影响 [J]. 黑龙江医药, 2024, 37 (02): 320-322.

[8] 袁媛. 拉贝洛尔低分子肝素联合治疗对妊高症患者凝血功能及妊娠结局的影响 [J]. 系统医学, 2023, 8 (21): 159-162. 

[9] 蔡慧. 硫酸镁、硝苯地平联合拉贝洛尔治疗妊高症的效果及安全性分析 [J]. 实用妇科内分泌电子杂志, 2022, 9 (20): 45-47.

[10] 廖飞娥. 硫酸镁联合拉贝洛尔治疗妊娠期高血压的临床效果及可行性分析 [J]. 中国现代药物应用, 2024, 18 (09): 85-88.

引用本文

普月, 拉贝洛尔辅助硫酸镁治疗妊高症患者的价值[J]. 国际临床研究杂志, 2024; 8: (7) : 75-77.